This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring

€500 savings end in:

  • 00
  • 00
  • 00
  • 00
March 18–20, 2024 | Barcelona, SpainMarch 26–27, 2024 | Digital Partnering

Jack O’Meara
CEO at Ochre Bio


Jack O'Meara is Co-founder and CEO of Ochre Bio, a biotechnology company developing RNA therapies for chronic liver diseases. Using breakthroughs in genomics, computation and organ perfusion, Ochre hopes to turn the tide on one of the most pressing healthcare challenges of our time. In his role as CEO, Jack has raised over $40M from renowned global investors, built a seasoned executive team and board, and progressed a pipeline of novel RNAi medicines towards the clinic. Prior to Ochre, he worked in management consulting where he supported the global launch of Zolgensma at AveXis. Mr. O'Meara graduated technical degrees from the University of Galway, Ireland, and Notre Dame, US, and his work has appeared in the Wall Street Journal and the Financial Times.

Agenda Sessions

  • In collaboration with YVC Collective - In sync or offbeat: are the expectations of VCs and entrepreneurs aligned?